Stereotaxis (STXS)

• Market cap: $181M
• 1 day: -2.76%
• 5 days: -7.46%
• 1 month: 0.00%
• 3 months: 18.54%
• 6 months: -9.83%
• Year to date: -7.86%
• 1 year: 10.47%
• 5 years: -59.58%
• 10 years: 71.54%
• Sector: Healthcare
• Industry: Medical Devices

About: Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Employees: 139

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

142% more call options, than puts

Call options by funds: $196K | Put options by funds: $81K

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

28% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 25

4% more funds holding

Funds holding: 84 [Q4 2024] → 87 (+3) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 3 [Q4 2024] → 3 (+0) [Q1 2025]

2.69% less ownership

Funds ownership: 48.58% [Q4 2024] → 45.89% (-2.69%) [Q1 2025]

26% less capital invested

Capital invested by funds: $93.8M [Q4 2024] → $69.4M (-$24.4M) [Q1 2025]